business
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
Key takeaways
- WGS NKTR JANX PRCT BSX On May 15, 2026, Prosight Management disclosed a purchase of 468,463 shares of Gene Dx Holdings (NASDAQ:WGS), an estimated $42.72 million trade based on quarterly average pricing.
- According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, Prosight Management increased its holdings in Gene Dx Holdings by 468,463 shares.
- The position now comprises roughly 5.51% of Prosight s 13F reportable assets under management.
WGS NKTR JANX PRCT BSX On May 15, 2026, Prosight Management disclosed a purchase of 468,463 shares of Gene Dx Holdings (NASDAQ:WGS), an estimated $42.72 million trade based on quarterly average pricing.
According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, Prosight Management increased its holdings in Gene Dx Holdings by 468,463 shares. The estimated transaction value, based on the average unadjusted closing price for the first quarter of 2026, was $42.72 million. The quarter-end value of the position, reflecting both price change and share addition, increased by $26.46 million to $33.62 million.
The position now comprises roughly 5.51% of Prosight s 13F reportable assets under management.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop